CN1157564A - 用氮杂螺烷治疗机会性感染的方法 - Google Patents

用氮杂螺烷治疗机会性感染的方法 Download PDF

Info

Publication number
CN1157564A
CN1157564A CN95195052A CN95195052A CN1157564A CN 1157564 A CN1157564 A CN 1157564A CN 95195052 A CN95195052 A CN 95195052A CN 95195052 A CN95195052 A CN 95195052A CN 1157564 A CN1157564 A CN 1157564A
Authority
CN
China
Prior art keywords
chemical compound
general formula
treatment
administration
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95195052A
Other languages
English (en)
Chinese (zh)
Inventor
A·M·巴格
P·J·布赫尔斯基
D·J·赫茨克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of CN1157564A publication Critical patent/CN1157564A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN95195052A 1994-07-23 1995-07-14 用氮杂螺烷治疗机会性感染的方法 Pending CN1157564A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods
GB9414902.8 1994-07-23

Publications (1)

Publication Number Publication Date
CN1157564A true CN1157564A (zh) 1997-08-20

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95195052A Pending CN1157564A (zh) 1994-07-23 1995-07-14 用氮杂螺烷治疗机会性感染的方法

Country Status (15)

Country Link
EP (1) EP0804201A4 (hu)
JP (1) JPH10503202A (hu)
KR (1) KR970704446A (hu)
CN (1) CN1157564A (hu)
AU (1) AU684384B2 (hu)
BR (1) BR9508332A (hu)
CA (1) CA2195778A1 (hu)
CZ (1) CZ286482B6 (hu)
GB (1) GB9414902D0 (hu)
HU (1) HUT77379A (hu)
MX (1) MX9700626A (hu)
NO (1) NO310096B1 (hu)
NZ (1) NZ290974A (hu)
WO (1) WO1996003126A1 (hu)
ZA (1) ZA956098B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso

Also Published As

Publication number Publication date
MX9700626A (es) 1997-05-31
BR9508332A (pt) 1997-11-04
ZA956098B (en) 1996-05-23
HUT77379A (hu) 1998-04-28
GB9414902D0 (en) 1994-09-14
NO310096B1 (no) 2001-05-21
CZ20997A3 (en) 1997-10-15
JPH10503202A (ja) 1998-03-24
CZ286482B6 (en) 2000-04-12
NO970284L (no) 1997-03-19
KR970704446A (ko) 1997-09-06
NO970284D0 (no) 1997-01-22
EP0804201A1 (en) 1997-11-05
WO1996003126A1 (en) 1996-02-08
HU9700201D0 (en) 1997-04-28
NZ290974A (en) 1999-08-30
AU684384B2 (en) 1997-12-11
AU3190995A (en) 1996-02-22
EP0804201A4 (en) 2000-04-26
CA2195778A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
CN1227011C (zh) 治疗哮喘的药物及其用途
EP0463540B1 (en) Anti-virus agent
Singh et al. Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens
WO2006083678A2 (en) β-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS
SK138597A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
CN1267099C (zh) 对氧化毒性物质,特别是对心脏毒性物质具有保护作用的药物
US6242424B1 (en) Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
CN1157564A (zh) 用氮杂螺烷治疗机会性感染的方法
KR100866021B1 (ko) 돼지와 가금의 질병 및 감염 치료 및 예방용 조성물
NZ509859A (en) Use of camptothecin derivatives, with reduced gastrointestinal toxicity
CN1429558A (zh) 甘露聚糖肽注射液及其制备方法和使用方法
CN1671397A (zh) 烷基胆碱磷酸与抗肿瘤药的联合应用
CN1282458C (zh) 头孢羟氨苄干混悬及制备方法
EP0213692B1 (en) Use of hygromycin and epihygromycin in the treatment of swine dysentery
CN1158566A (zh) 用于预防和/或治疗病毒感染和各种炎症的药物组合物及其治疗方法
CN1098687C (zh) 氨基嘌呤抗病毒剂在治疗和预防潜伏性疱疹病毒感染中的用途
CN1526390A (zh) 一种匹多莫德的颗粒剂及其制备方法
CN1817868A (zh) 一组抗厌氧菌感染的奥硝唑类衍生物及其制备方法
IE58434B1 (en) Inhibition of tumor development
US7182962B2 (en) Immunostimulator for animals and humans, and method of preventing animal and human infectious diseases and cancer
CN1049818C (zh) 苯并噻吩类化合物的制药用途
US20220339175A1 (en) Application of Stachyose in Preparation of Drug for Treating Castration-Resistant Prostate Cancer
CN1130873A (zh) 用氮杂螺烷治疗hiv的方法
CN1679914A (zh) 还原型谷胱甘肽和依布硒啉的组合药物
CN1130871A (zh) 用取代的氮杂螺烷抑制人体免疫缺陷病毒的复制的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: SMITHKLINE BEECHAM CORP. TO: ANORMED INC

CP03 Change of name, title or address

Address after: Columbia, Canada

Applicant after: Anormed Inc.

Address before: American Pennsylvania

Applicant before: Smithkline Beechan Corp.

AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1001855

Country of ref document: HK